Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients. [electronic resource]
Producer: 20091029Description: 2449-57 p. digitalISSN:- 1572-0241
- Adult
- Antiviral Agents -- therapeutic use
- Area Under Curve
- Chi-Square Distribution
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Hepatitis B Surface Antigens -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B, Chronic -- blood
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Lamivudine -- therapeutic use
- Longitudinal Studies
- Male
- Polyethylene Glycols -- therapeutic use
- Recombinant Proteins
- Statistics, Nonparametric
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.